Introduction
Respiratory Syncytial Virus (RSV) is a major cause of respiratory infections in infants, leading to significant hospitalizations and deaths globally. Despite its impact, there are no universal treatments or preventive solutions, making RSV an urgent unmet medical need. Recent advances in vaccines and monoclonal antibodies benefit high-income countries (HICs), but low- and middle-income countries (LMICs) face barriers like delivery inequities, low awareness, and policy challenges.
The study will engage pediatric societies to assess challenges and readiness for RSV interventions and vaccine inclusion in national programs.
Collaborative Effort:
The International Pediatric Association (IPA), representing 149 countries, collaborates with Sanofi, a global vaccine leader, to develop a plan for data generation, dissemination, and stakeholder engagement to bridge gaps in RSV awareness and policy-making worldwide.
Project Objectives
- 1. Mapping: The primary objective is to assess opportunities and barriers for RSV (Respiratory Syncytial Virus) policy implementation through IPA’s network, focusing on pediatricians. This involves identifying key gaps and challenges to formulate effective strategies.
- 2. Planning: Develop a comprehensive end-to-end plan for assessing RSV-related policies and disseminating the findings. This plan will guide the project’s progression and ensure alignment with its goals.
- 3. Engagement: Engage with key decision-makers in selected countries to implement and promote RSV-oriented policies. Collaboration with policymakers, stakeholders, and experts will be essential to achieve sustainable outcomes.
Activities
Global Survey: A global survey will be conducted among IPA member societies across over 150 countries. The objective is to gather broad insights and data regarding RSV policy landscapes.
Targeted Survey: A more focused survey targeting 100-500 pediatricians in 10 selected countries will be conducted. This will help gain country-specific perspectives and actionable insights.
Dissemination Plan:
- • Publication: The study’s findings will be published in a peer-reviewed journal to enhance its scientific credibility and reach.
- • International Webinars: Webinars will be conducted in English, French, and Spanish to disseminate the results globally and foster knowledge sharing.
- • Event Sessions: Dedicated sessions will be organized during the IPA Congress and the Vaccine Trust Project workshop to present the findings to key audiences.
- • Social Media: Results will be shared across various social media platforms to engage a wider audience and increase awareness.
This project marks a significant initiative to understand and address barriers to RSV policy implementation. Through comprehensive surveys, stakeholder engagement, and effective dissemination, the project aims to pave the way for informed decision-making and impactful policy changes in RSV prevention and management.
